Home › Funds › Ally Bridge Group (NY) LLC › PMN

Ally Bridge Group (NY) LLC position in PMN

PROMIS NEUROSCIENCES INC · Health Care

Ally Bridge Group (NY) LLC reported holding 620,319 shares of PMN (PROMIS NEUROSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$8.2M, representing 7.22% of its reported portfolio and ranking #4 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed PMN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)620.32K sh
Reported value held$8.16M
Portfolio Weight7.22%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ally Bridge Group (NY) LLC's PMN position evolved

Ally Bridge Group (NY) LLC first disclosed a stake in PMN in Q3 2023 at 531,915 shares (US$1.1M). The position peaked in Q2 2026 at 620,319 shares, worth US$8.2M. Across 12 filings, Ally Bridge Group (NY) LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 620,319 shares valued at US$8.2M — an increase of 206,100 shares quarter over quarter.. Notable position changes include a 101% increase in Q4 2023 (shares rose 30% over the following quarter), a 367% increase in Q3 2025 (shares fell 36% over the following quarter), a 96% trim in Q4 2025 (shares rose 86% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 531.91K $1.05M New
Q4 2023 1.07M $1.23M Add
Q1 2024 1.06M $2.02M Reduce
Q2 2024 1.06M $1.59M Hold
Q3 2024 1.59M $1.99M Add
Q4 2024 1.59M $1.51M Hold
Q1 2025 1.48M $1.03M Reduce
Q2 2025 1.33M $645.60K Reduce
Q3 2025 6.23M $2.65M Add
Q4 2025 249.34K $1.70M Reduce
Q1 2026 414.22K $5.26M Add
Q2 2026 620.32K $8.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PMN and 13F data

PMN (PROMIS NEUROSCIENCES INC) is a Health Care company. 29 other funds we track also report a position in PMN — the largest reported positions include Trails Edge Capital Partners, LP (US$7.3M), Yu Fan (US$4.3M), Squadron Capital Management LLC (US$4.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PMN

All PMN fund holders →

FAQ

How long has Ally Bridge Group (NY) LLC held PMN?

Ally Bridge Group (NY) LLC has disclosed PMN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Ally Bridge Group (NY) LLC's current position in PMN?

As of Q2 2026, Ally Bridge Group (NY) LLC holds 620.32K shares of PMN (PROMIS NEUROSCIENCES INC), valued at $8.16M, representing 7.22% of its reported portfolio and ranking #4.

Has Ally Bridge Group (NY) LLC been buying or selling PMN?

In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC increased its position in PMN. The position peaked in Q2 2026 at 620.32K shares.

Which other funds hold PMN?

Other major institutional holders of PMN include Trails Edge Capital Partners, LP, Yu Fan, Squadron Capital Management LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.